# The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients

> **NCT00696761** · PHASE4 · COMPLETED · sponsor: **Asan Medical Center** · enrollment: 232 (actual)

## Conditions studied

- BPH

## Interventions

- **DRUG:** Alfuzosin
- **DRUG:** Alfuzosin
- **DRUG:** Alfuzosin
- **DRUG:** Alfuzosin

## Key facts

- **NCT ID:** NCT00696761
- **Lead sponsor:** Asan Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-05
- **Primary completion:** 2008-07
- **Final completion:** 2008-08
- **Target enrollment:** 232 (ACTUAL)
- **Last updated:** 2021-02-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696761

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696761, "The Long Term Effects of Alfuzosin(Xatral XL) in Lower Urinary Tract Symptoms(LUTS)/BPH Patients". Retrieved via MORVS 2026-10-13 from https://api.morvs.ai/clinical/NCT00696761. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*